Copyright © 2008 Seth T. Walk and Vincent B. Young. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. L. V. Holdeman, I. J. Good, and W. E. C. Moore, “Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress,” Applied and Environmental Microbiology, vol. 31, no. 3, pp. 359–375, 1976.
2. W. E. C. Moore and L. V. Holdeman, “Human fecal flora: the normal flora of 20 Japanese Hawaiians,” Journal of Applied Microbiology, vol. 27, no. 5, pp. 961–979, 1974.
3. M. Rajilić-Stojanović, H. Smidt, and W. M. de Vos, “Diversity of the human gastrointestinal tract microbiota revisited,” Environmental Microbiology, vol. 9, no. 9, pp. 2125–2136, 2007. View at Publisher · View at Google Scholar · View at PubMed
4. C. S. Riesenfeld, P. D. Schloss, and J. Handelsman, “Metagenomics: genomic analysis of microbial communities,” Annual Review of Genetics, vol. 38, pp. 525–552, 2004. View at Publisher · View at Google Scholar · View at PubMed
5. P. D. Schloss and J. Handelsman, “Biotechnological prospects from metagenomics,” Current Opinion in Biotechnology, vol. 14, no. 3, pp. 303–310, 2003. View at Publisher · View at Google Scholar
6. M. Castillo, G. Skene, M. Roca, et al., “Application of 16S rRNA gene-targetted fluorescence in situ hybridization and restriction fragment length polymorphism to study porcine microbiota along the gastrointestinal tract in response to different sources of dietary fibre,” FEMS Microbiology Ecology, vol. 59, no. 1, pp. 138–146, 2007. View at Publisher · View at Google Scholar · View at PubMed
7. D. A. Peterson, D. N. Frank, N. R. Pace, and J. I. Gordon, “Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases,” Cell Host & Microbe, vol. 3, no. 6, pp. 417–427, 2008. View at Publisher · View at Google Scholar · View at PubMed
8. E. G. Zoetendal, A. von Wright, T. Vilpponen-Salmela, K. Ben-Amor, A. D. L. Akkermans, and W. M. de Vos, “Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces,” Applied and Environmental Microbiology, vol. 68, no. 7, pp. 3401–3407, 2002. View at Publisher · View at Google Scholar
9. P. B. Eckburg, E. M. Bik, C. N. Bernstein, et al., “Diversity of the human intestinal microbial flora,” Science, vol. 308, no. 5728, pp. 1635–1638, 2005. View at Publisher · View at Google Scholar · View at PubMed
10. P. Marteau, P. Pochart, J. Doré, C. Béra-Maillet, A. Bernalier, and G. Corthier, “Comparative study of bacterial groups within the human cecal and fecal microbiota,” Applied and Environmental Microbiology, vol. 67, no. 10, pp. 4939–4942, 2001. View at Publisher · View at Google Scholar
11. K. T. Konstantinidis and J. M. Tiedje, “Prokaryotic taxonomy and phylogeny in the genomic era: advancements and challenges ahead,” Current Opinion in Microbiology, vol. 10, no. 5, pp. 504–509, 2007. View at Publisher · View at Google Scholar · View at PubMed
12. D. N. Frank and N. R. Pace, “Gastrointestinal microbiology enters the metagenomics era,” Current Opinion in Gastroenterology, vol. 24, no. 1, pp. 4–10, 2008. View at Publisher · View at Google Scholar · View at PubMed
13. W. B. Whitman, D. C. Coleman, and W. J. Wiebe, “Prokaryotes: the unseen majority,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 12, pp. 6578–6583, 1998. View at Publisher · View at Google Scholar
14. D. Kelly, T. King, and R. Aminov, “Importance of microbial colonization of the gut in early life to the development of immunity,” Mutation Research, vol. 622, no. 1-2, pp. 58–69, 2007. View at Publisher · View at Google Scholar · View at PubMed
15. E. Lindberg, F. Nowrouzian, I. Adlerberth, and A. E. Wold, “Long-time persistence of superantigen-producing Staphylococus aureus strains in the intestinal microflora of healthy infants,” Pediatric Research, vol. 48, no. 6, pp. 741–747, 2000. View at Publisher · View at Google Scholar
16. F. Nowrouzian, B. Hesselmar, R. Saalman, et al., “Escherichia coli in infants' intestinal microflora: colonization rate, strain turnover, and virulence gene carriage,” Pediatric Research, vol. 54, no. 1, pp. 8–14, 2003. View at Publisher · View at Google Scholar · View at PubMed
17. C. Palmer, E. M. Bik, D. B. DiGiulio, D. A. Relman, and P. O. Brown, “Development of the human infant intestinal microbiota,” PLoS Biology, vol. 5, no. 7, p. e177, 2007. View at Publisher · View at Google Scholar · View at PubMed
18. S. T. Shulman, H. C. Friedmann, and R. H. Sims, “Theodor Escherich: the first pediatric infectious diseases physician?,” Clinical Infectious Diseases, vol. 45, no. 8, pp. 1025–1029, 2007. View at Publisher · View at Google Scholar · View at PubMed
19. K. Kurokawa, T. Itoh, T. Kuwahara, et al., “Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes,” DNA Research, vol. 14, no. 4, pp. 169–181, 2007. View at Publisher · View at Google Scholar · View at PubMed
20. L. Dethlefsen, M. McFall-Ngai, and D. A. Relman, “An ecological and evolutionary perspective on humang-microbe mutualism and disease,” Nature, vol. 449, no. 7164, pp. 811–818, 2007. View at Publisher · View at Google Scholar · View at PubMed
21. R. E. Ley, M. Hamady, C. Lozupone, et al., “Evolution of mammals and their gut microbes,” Science, vol. 320, no. 5883, pp. 1647–1651, 2008. View at Publisher · View at Google Scholar · View at PubMed
22. D. Tilman, “Niche tradeoffs, neutrality, and community structure: a stochastic theory of resource competition, invasion, and community assembly,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 30, pp. 10854–10861, 2004. View at Publisher · View at Google Scholar · View at PubMed
23. J. Penders, C. Thijs, C. Vink, et al., “Factors influencing the composition of the intestinal microbiota in early infancy,” Pediatrics, vol. 118, no. 2, pp. 511–521, 2006. View at Publisher · View at Google Scholar · View at PubMed
24. R. E. Ley, F. Bäckhed, P. Turnbaugh, C. A. Lozupone, R. D. Knight, and J. I. Gordon, “Obesity alters gut microbial ecology,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 31, pp. 11070–11075, 2005. View at Publisher · View at Google Scholar · View at PubMed
25. J. Dicksved, J. Halfvarson, M. Rosenquist, et al., “Molecular analysis of the gut microbiota of identical twins with Crohn's disease,” The ISME Journal, vol. 2, no. 7, pp. 716–727, 2008. View at Publisher · View at Google Scholar · View at PubMed
26. G. C. Parkes, J. Brostoff, K. Whelan, and J. D. Sanderson, “Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment,” American Journal of Gastroenterology, vol. 103, no. 6, pp. 1557–1567, 2008. View at Publisher · View at Google Scholar · View at PubMed
27. M. C. Noverr and G. B. Huffnagle, “The ‘microflora hypothesis’ of allergic diseases,” Clinical and Experimental Allergy, vol. 35, no. 12, pp. 1511–1520, 2005. View at Publisher · View at Google Scholar · View at PubMed
28. T. H. Keitt, “Coherent ecological dynamics induced by large-scale disturbance,” Nature, vol. 454, no. 7202, pp. 331–334, 2008. View at Publisher · View at Google Scholar · View at PubMed
29. M. C. Barc, F. Bourlioux, L. Rigottier-Gois, et al., “Effect of amoxicillin-clavulanic acid on human fecal flora in a gnotobiotic mouse model assessed with fluorescence hybridization using group-specific 16S rRNA probes in combination with flow cytometry,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 4, pp. 1365–1368, 2004. View at Publisher · View at Google Scholar
30. C. Jernberg, S. Löfmark, C. Edlund, and J. K. Jansson, “Long-term ecological impacts of antibiotic administration on the human intestinal microbiota,” The ISME Journal, vol. 1, no. 1, pp. 56–66, 2007. View at Publisher · View at Google Scholar · View at PubMed
31. M. Membrez, F. Blancher, M. Jaquet, et al., “Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice,” The FASEB Journal, vol. 22, no. 7, pp. 2416–2426, 2008. View at Publisher · View at Google Scholar · View at PubMed
32. A. Sullivan, C. Edlund, and C. E. Nord, “Effect of antimicrobial agents on the ecological balance of human microflora,” Lancet Infectious Diseases, vol. 1, no. 2, pp. 101–114, 2001. View at Publisher · View at Google Scholar · View at PubMed
33. C. J. Donskey, A. M. Hujer, S. M. Das, N. J. Pultz, R. A. Bonomo, and L. B. Rice, “Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients,” Journal of Microbiological Methods, vol. 54, no. 2, pp. 249–256, 2003. View at Publisher · View at Google Scholar
34. M. Barman, D. Unold, K. Shifley, et al., “Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract,” Infection and Immunity, vol. 76, no. 3, pp. 907–915, 2008. View at Publisher · View at Google Scholar · View at PubMed
35. I. Sekirov, N. M. Tam, M. Jogova, et al., “Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection,” Infection and Immunity, vol. 76, no. 10, pp. 4726–4736, 2008. View at Publisher · View at Google Scholar · View at PubMed
36. T. Pédron and P. Sansonetti, “Commensals, bacterial pathogens and intestinal inflammation: an intriguing ménage à trois,” Cell Host & Microbe, vol. 3, no. 6, pp. 344–347, 2008. View at Publisher · View at Google Scholar · View at PubMed
37. B. Stecher and W.-D. Hardt, “The role of microbiota in infectious disease,” Trends in Microbiology, vol. 16, no. 3, pp. 107–114, 2008. View at Publisher · View at Google Scholar · View at PubMed
38. R. Freter, “The fatal enteric cholera infection in the guinea pig, achieved by inhibition of normal enteric flora,” The Journal of Infectious Diseases, vol. 97, no. 1, pp. 57–65, 1955.
39. D. van der Waaij, “The ecology of the human intestine and its consequences for overgrowth by pathogens such as Clostridium difficile,” Annual Review of Microbiology, vol. 43, pp. 69–87, 1989. View at Publisher · View at Google Scholar
40. N. J. Pultz, U. Stiefel, S. Subramanyan, M. S. Helfand, and C. J. Donskey, “Mechanisms by which anaerobic microbiota inhibit the establishment in mice of intestinal colonization by vancomycin-resistant Enterococcus,” The Journal of Infectious Diseases, vol. 191, no. 6, pp. 949–956, 2005. View at Publisher · View at Google Scholar · View at PubMed
41. J. G. Bartlett, “Antibiotic-associated diarrhea,” The New England Journal of Medicine, vol. 346, no. 5, pp. 334–339, 2002. View at Publisher · View at Google Scholar · View at PubMed
42. L. Beaugerie and J. C. Petit, “Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea,” Best Practice & Research Clinical Gastroenterology, vol. 18, no. 2, pp. 337–352, 2004.
43. L. Beaugerie, A. Flahault, F. Barbut, et al., “Antibiotic-associated diarrhoea and Clostridium difficile in the community,” Alimentary Pharmacology & Therapeutics, vol. 17, no. 7, pp. 905–912, 2003. View at Publisher · View at Google Scholar
44. J. Wiström, S. R. Norrby, E. B. Myhre, et al., “Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study,” Journal of Antimicrobial Chemotherapy, vol. 47, no. 1, pp. 43–50, 2001. View at Publisher · View at Google Scholar
45. G. Iapichino, M. L. Callegari, S. Marzorati, et al., “Impact of antibiotics on the gut microbiota of critically ill patients,” Journal of Medical Microbiology, vol. 57, no. 8, pp. 1007–1014, 2008. View at Publisher · View at Google Scholar · View at PubMed
46. J. G. Bartlett and D. N. Gerding, “Clinical recognition and diagnosis of Clostridium difficile infection,” Clinical Infectious Diseases, vol. 46, pp. S12–S18, 2008. View at Publisher · View at Google Scholar · View at PubMed
47. E. J. Kuijper, B. Coignard, and P. Tüll, “Emergence of Clostridium difficile-associated disease in North America and Europe,” Clinical Microbiology and Infection, vol. 12, pp. 2–18, 2006. View at Publisher · View at Google Scholar · View at PubMed
48. L. C. McDonald, B. Coignard, E. Dubberke, X. Song, T. Horan, and P. K. Kutty, “Recommendations for surveillance of Clostridium difficile-associated disease,” Infection Control and Hospital Epidemiology, vol. 28, no. 2, pp. 140–145, 2007. View at Publisher · View at Google Scholar · View at PubMed
49. L. C. McDonald, M. Owings, and D. B. Jernigan, “Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003,” Emerging Infectious Diseases, vol. 12, no. 3, pp. 409–415, 2006.
50. E. Weir and K. Flegel, “Protecting against Clostridium difficile illness,” Canadian Medical Association Journal, vol. 172, no. 9, p. 1178, 2005. View at Publisher · View at Google Scholar · View at PubMed
51. T. Rabatsky-Ehr, K. Purviance, D. Mlynarski, P. Mshar, J. Hadler, and L. Sosa, “Surveillance for community-associated Clostridium difficile—Connecticut, 2006,” Morbidity and Mortality Weekly Report, vol. 57, no. 13, pp. 340–343, 2008.
52. J. Halsey, “Current and future treatment modalities for Clostridium difficile-associated disease,” American Journal of Health-System Pharmacy, vol. 65, no. 8, pp. 705–715, 2008. View at Publisher · View at Google Scholar · View at PubMed
53. T. Monaghan, T. Boswell, and Y. R. Mahida, “Recent advances in Clostridium difficile-associated disease,” Gut, vol. 57, no. 6, pp. 850–860, 2008. View at Publisher · View at Google Scholar · View at PubMed
54. M. A. Miller, “Clinical management of Clostridium difficile-associated disease,” Clinical Infectious Diseases, vol. 45, pp. S122–S128, 2007. View at Publisher · View at Google Scholar · View at PubMed
55. L. V. McFarland, G. W. Elmer, and C. M. Surawicz, “Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease,” American Journal of Gastroenterology, vol. 97, no. 7, pp. 1769–1775, 2002. View at Publisher · View at Google Scholar
56. Y. Tang-Feldman, S. Mayo, J. Silva, Jr., and S. H. Cohen, “Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent Clostridium difficile-associated diarrhea,” Journal of Clinical Microbiology, vol. 41, no. 7, pp. 3413–3414, 2003. View at Publisher · View at Google Scholar
57. M. H. Wilcox, W. N. Fawley, C. D. Settle, and A. Davidson, “Recurrence of symptoms in Clostridium difficile infection—relapse or reinfection?,” Journal of Hospital Infection, vol. 38, no. 2, pp. 93–100, 1998. View at Publisher · View at Google Scholar
58. J. G. Bartlett, T. W. Chang, M. Gurwith, S. L. Gorbach, and A. B. Onderdonk, “Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia,” The New England Journal of Medicine, vol. 298, no. 10, pp. 531–534, 1978.
59. R. Ricciardi, D. A. Rothenberger, R. D. Madoff, and N. N. Baxter, “Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States,” Archives of Surgery, vol. 142, no. 7, pp. 624–631, 2007. View at Publisher · View at Google Scholar · View at PubMed
60. B. Hubert, V. G. Loo, A.-M. Bourgault, et al., “A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec,” Clinical Infectious Diseases, vol. 44, no. 2, pp. 238–244, 2007. View at Publisher · View at Google Scholar · View at PubMed
61. L. Kyne, M. B. Hamel, R. Polavaram, and C. P. Kelly, “Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile,” Clinical Infectious Diseases, vol. 34, no. 3, pp. 346–353, 2002. View at Publisher · View at Google Scholar · View at PubMed
62. M. Zerey, B. L. Paton, A. E. Lincourt, K. S. Gersin, K. W. Kercher, and B. T. Heniford, “The burden of Clostridium difficile in surgical patients in the United States,” Surgical Infections, vol. 8, no. 6, pp. 557–566, 2007. View at Publisher · View at Google Scholar · View at PubMed
63. V. B. Young and T. M. Schmidt, “ntibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota,” Journal of Clinical Microbiology, vol. 42, no. 3, pp. 1203–1206, 2004. View at Publisher · View at Google Scholar
64. K. H. Wilson, “The microecology of Clostridium difficile,” Clinical Infectious Diseases, vol. 16, pp. S214–S218, 1993.
65. J. Aas, C. E. Gessert, and J. S. Bakken, “Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube,” Clinical Infectious Diseases, vol. 36, no. 5, pp. 580–585, 2003. View at Publisher · View at Google Scholar · View at PubMed
66. M. Tvede and J. Rask-Madsen, “Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients,” The Lancet, vol. 1, no. 8648, pp. 1156–1160, 1989. View at Publisher · View at Google Scholar
67. A. Pillai and R. L. Nelson, “Probiotics for treatment of Clostridium difficile-associated colitis in adults,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD004611, 2008. View at Publisher · View at Google Scholar · View at PubMed
68. J. Y. Chang, D. A. Antonopoulos, A. Kalra, et al., “Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea,” The Journal of Infectious Diseases, vol. 197, no. 3, pp. 435–438, 2008. View at Publisher · View at Google Scholar · View at PubMed
69. N. J. Gotelli and R. K. Colwell, “Quantifying biodiversity: procedures and pitfalls in the measurement and comparison of species richness,” Ecology Letters, vol. 4, no. 4, pp. 379–391, 2001. View at Publisher · View at Google Scholar
70. A. Sundquist, S. Bigdeli, R. Jalili, et al., “Bacterial flora-typing with targeted, chip-based Pyrosequencing,” BMC Microbiology, vol. 7, article 108, pp. 1–11, 2007. View at Publisher · View at Google Scholar · View at PubMed
71. Z. Liu, C. Lozupone, M. Hamady, F. D. Bushman, and R. Knight, “Short pyrosequencing reads suffice for accurate microbial community analysis,” Nucleic Acids Research, vol. 35, no. 18, p. e120, 2007. View at Publisher · View at Google Scholar · View at PubMed